Skip to main content
. 2020 Dec 10;147(4):1031–1040. doi: 10.1007/s00432-020-03486-2

Table 2.

Correlation between GATA6 and other molecular markers within the patient cohort

Factor Total GATA6 p value
Negative Positive
HER2
 Normal 300 87.7% 268 89.3% 32 10.7%
 Mutated 42 12.3% 41 97.6% 1 2.4% 0.089
MHC1
 Loss 106 29.4% 101 95.3% 5 4.7%
 Normal 254 70.6% 227 89.4% 27 10.6% 0.072
ARIDA 1A
 Loss 45 9.5% 44 97.8% 1 2.2%
 Normal 427 90.5% 381 89.2% 46 10.8% 0.068
C-myc
 Normal 418 87.8% 379 90.7% 39 9.3%
 Amplified 58 12.2% 48 82.8% 10 17.2% 0.063
KRAS
 Normal 402 82.4% 366 91.0% 36 9.0%
 Mutated 86 17.6% 73 84.9% 13 15.1% 0.084
PIK3CA
 Normal 415 94.5% 379 91.3% 36 8.7%
 Mutated 24 5.5% 15 62.5% 9 37.5%  < 0.001